Structure |
Chemical Name |
CAS |
MF |
|
ERYTHROMYCIN IMPURITY G |
|
|
|
Amylmetacresol EP impurity E |
|
|
|
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide |
2232201-72-6 |
C11H18N2O3 |
|
methyl 1-hydroxy-2-oxoindoline-6-carboxylate |
1895918-24-7 |
C10H9NO4 |
|
Dapagliflozin Impurity (MW: 437Da) |
|
|
|
Cetirizine Impurity BHA |
|
|
|
Macitentandesbromopyrimidine Impurity |
|
|
|
Cilastatin EP Impurity H |
|
|
|
Febuxostat Impurity 130 |
1643131-93-4 |
C20H25NO5S |
|
(2-Chlorophenyl)diphenylmethanol |
|
|
|
Nilotinib Impurity 27 |
1807606-80-9 |
C28H22F3N7O2 |
|
Vonoprazan Impurity 53 |
|
|
|
Vonoprazan Impurity 61 |
|
|
|
Emtricitabine Ring-opening Impurity |
|
|
|
Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer) |
|
|
|
Escitalopram Butyryl Impurity |
1803244-58-7 |
C25H33FN2O2 |
|
Oseltamivir isomer impurity |
|
|
|
Ethyl 4-bromo-3-hydroxybutyrate |
32224-01-4 |
C6H11BrO3 |
|
(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate |
2216755-67-6 |
C28H37NO5 |
|
1,2-Dihydro Diethyl Loteprednol Carbonate |
82048-81-5 |
C26H36O9 |
|
Nilotinib 3-Imidazolyl N-oxide |
2139382-75-3 |
C28H22F3N7O2 |
|
α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol |
857786-66-4 |
C19H25NO2 |
|
sodium 5-methoxy-2-sulfinatobenzo[d]imidazol-1-id |
|
|
|
Pramipexole 828 Impurity |
|
|
|
E-Ceftazidime Oxide Impurity |
|
|
|
Cefuroxime Impurity D Δ3-Isomer |
|
|
|
Ampicillin Open-Ring Formylation Impurity |
|
|
|
Faropenem Degradation Impurity A |
|
|
|
2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid |
|
|
|
Eribulin Impurity 2 |
|
|
|
(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate |
|
|
|
(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole |
|
|
|
Peramivir Impurity 22 |
|
|
|
Olaparib Impurity 58 |
848136-41-4 |
C22H21FN4O3 |
|
Fluconazole Impurity 4 |
168479-96-7 |
C10H7F2N3O |
|
Roxatidine Impurity 7 |
876497-65-3 |
C7H6N2O2 |
|
Sparfloxacin Impurity |
126457-99-6 |
C19H21F2N3O3 |
|
Peramivir Impurity 39 |
|
|
|
Imatinib impurity 39 |
|
|
|
7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE |
203395-59-9 |
C13H14BrNO2 |
|
DESMETHYL ATOMOXETINE HYDROCHLORIDE |
881995-46-6 |
C16H19NO.ClH |
|
2-HYDROXY-5-BENZYLOXYACETOPHENONE |
30992-63-3 |
C15H14O3 |
|
2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE |
102804-82-0 |
C15H15N3OS |
|
2-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZONITRILE |
864069-00-1 |
C13H17N3 |
|
Afatinib impurity 84 |
|
|
|
Sugammadex sodium Impurity 40 |
|
|
|
Sugammadex sodium Impurity 44 |
|
|
|
Sugammadex sodium Impurity 49 |
|
|
|
Cefazolin Impurity EP-E |
|
|
|
Canagliflozin Impurity 70 |
|
|
|
Dapoxetine impurity 66 |
|
|
|
EP Impurity Catalog |
|
|
|
2-[(5-CARBOXY-4-METHOXY-3-METHYLPYRID-2-YL)-METHYLSULFO]-5-METHOXYBENZIMIDAZOLE |
120003-72-7 |
C17H17N3O5S |
|
Gadobutrol Impurity 3 |
|
|
|
Empagliflozin Impurity 84 |
|
|
|
Iohexol Impurity O |
|
|
|
Avibactam sodium Impurity CES |
|
|
|
(2,5-dichlorophenyl)(4-ethoxyphenyl)methanone |
1097076-93-1 |
C15H12Cl2O2 |
|
Lenvatinib impurity LFZZ-10 |
|
C11H8Cl2N2O2 |
|
(2S,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
|
|
Febuxostat Impurity 98 |
|
|
|
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
|
1-(4-bromo-3,5-dimethoxyphenyl)ethanone |
1333472-28-8 |
C10H11BrO3 |
|
Ticagrelor Impurity 117 |
|
|
|
Ticagrelor Impurity 136 |
|
|
|
Phenol, 2-(diphenylmethyl)-5-methyl- |
411239-19-5 |
C20H18O |
|
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-(formylamino)-, ethyl ester, (3R,4R,5S)- |
2148317-96-6 |
C17H28N2O5 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl- |
2245167-80-8 |
C17H19ClN4O2 |
|
Posaconazole impurity 18 |
1819334-66-1 |
C44H49F2N8O4+ |
|
(4S,6R)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylic acid |
2095786-11-9 |
C13H22O6 |
|
Crisaborole intermediate |
2354382-27-5 |
C14H8BCl2NO3 |
|
Ropivacaine Impurity 48 |
|
|
|
2,4-Heptadienoic acid, 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-, (2Z,4E)- |
1148131-09-2 |
C33H31FN2O3 |
|
2(3H)-Furanone, dihydro-4-(1-methylethyl)-, (4S)- |
53657-15-1 |
C7H12O2 |
|
Crisaborole Impurity 9 HCl |
1187187-01-4 |
C14H15BClNO3 |
|
2H-Indol-2-one, 3-[[3,5-dimethyl-4-(1-pyrrolidinylcarbonyl)-1H-pyrrol-2-yl]methylene]-5-fluoro-1,3-dihydro- |
2135339-43-2 |
C20H20FN3O2 |
|
Nicergoline Impurity 02 |
|
|
|
Bromhexine ImpurityABCDEFGHJKL |
|
|
|
1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-16-8 |
C24H28FN3O |
|
impurity 37 |
|
|
|
Aprepitant impurity 3 |
|
|
|
sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
1,4,7,10-Tetraazacyclododecane-1,4-diacetic acid |
229312-34-9 |
C12H24N4O4 |
|
Pentanoic acid, 3-(bromomethyl)-4-methyl-, ethyl ester, (3S)- |
2432911-38-9 |
C9H17BrO2 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl]-5-methyl-7-propyl- |
2411340-39-9 |
C21H28N6O4S |
|
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- |
1187595-89-6 |
C17H19N7O3S |
|
4-methyl-N-(2-(methylamino)phenyl)-2-propyl-1H-benzo[d]imidazole-6-carboxamide |
884330-18-1 |
C19H22N4O |
|
Benzeneacetic acid, 3-(2-amino-1,1-dimethyl-2-oxoethyl)-α,α-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- |
2469244-33-3 |
C17H22N4O3 |
|
2,4(1H,3H)-Pyrimidinedione, 5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3-[(2R)-2-(hydroxyamino)-2-phenylethyl]-6-methyl- |
2486454-64-0 |
C28H24F5N3O4 |
|
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-hydroxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-94-0 |
C24H25Cl2N5O3 |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-, (6bR,10aS)- |
313368-81-9 |
C13H17N3 |
|
Ergoline-8-methanol, 1,6-dimethyl-, (8β)- (9CI) |
40170-12-5 |
C17H22N2O |
|
Avatrombopag Impurity 22 |
|
|
|
Avatrombopag Impurity 33 |
|
|
|
Cisatracurium besylate impurity 16 |
|
|
|
1-ACETYL-2-METHYLBENZIMIDAZOLE |
14678-81-0 |
C10H10N2O |
|
(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester |
103890-69-3 |
C14H16O3 |
|
1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)- |
1046533-62-3 |
C33H33FN2O6 |
|
Bimatoprost Impurity 22 |
|
|
|
Bumetanide Impurity 9 |
|
|